It is also known by different names like GLP-1 receptor drug, incretin mimetics, or GLP-1 analogues
A recent study suggests that the use of GLP-1 receptor agonists was associated with better outcomes compared with the use of DPP-4 inhibitors among patients with type 2 diabetes and advanced-stage chronic kidney disease
They are engineered molecules designed for this exact purpose, modified to resist enzymatic breakdown and maintain activity for days or even weeks
Its also physician-tested on GLP-1 patients
Mechanism of Action In preclinical research, CJC-1295 with DAC is studied for its interaction with growth hormone-releasing hormone (GHRH) receptors
So, its no surprise that several wellness- and supplement-focused brands have launched products intended to meet the moment, though each of the products discussed in this piece positions itself slightly differently and uses different ingredients